Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:19 AM
Ignite Modification Date:
2025-12-25 @ 4:19 AM
NCT ID:
NCT03705520
Eligibility Criteria:
Inclusion Criteria:
PD Subjects Inclusion:
* 40-80 years of age
* Previously diagnosed with Parkinson's disease
* Parkinson's disease stage between 1-4
* Are willing to participate in the study
Healthy control/ Spouse/ 1st degree relative Inclusion:
* Adults 40-80 years of age
* No clinical evidence of neurological disorders including Parkinson's disease
* Live in the same household as the Parkinson Disease patient or is a first degree relative of the PD patient or an independent healthy control
* Are willing to participate in the study
Exclusion Criteria:
PD Subjects Exclusion:
* History of GI diseases (except for hemorrhoids or occasional (\<3 times a week) heartburn) like Inflammatory bowel disease or Celiac disease.
* Antibiotic use within last 12 weeks.
* Use of probiotic supplement except yogurt.
* Intentional change in diet.
* Chronic use of NSAIDS. A washout period of 3 weeks is needed before the subject could be enrolled into the study. Low dose aspirin is allowed.
Healthy control/ Spouse/ 1st degree relative Exclusion:
* History of GI diseases (except for hemorrhoids or occasional (\<3 times a week) heartburn) like Inflammatory bowel disease or Celiac disease.
* Antibiotic use within last 12 weeks.
* Use of probiotic supplement except yogurt.
* Intentional change in diet.
* Chronic use of NSAIDS. A washout period of 3 weeks is needed before the subject could be enrolled into the study. Low dose aspirin is allowed
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
80 Years
Study:
NCT03705520
Study Brief:
Protocol Section:
NCT03705520